CLB
Core Laboratories Inc. /DE/Company Information
- Company Name
- Core Laboratories Inc. /DE/
- CIK
- CIK0001958086
- Category
- Large accelerated filer
- Ticker: Exchange
- CLB: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 01 Energy & Transportation
- SIC
- 1389
- SIC Description
- Oil & Gas Field Services, NEC
- Ticker
- CLB
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-31
- Last sale
- —
- Shares purchased (TTM)
- 5,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 52,538,152
- Shares outstanding
- 46,030,000
- Ownership
- 114.14%
Earnings Market Reaction
- Filing date
- 2026-07-30
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 23 | 23 | 23 | 26 | 31 | 22 | 19 | 21 | 18 | 15 | 15 | 17 | ||||||
| Accounts Receivable Net Current | 109 | 108 | 114 | 110 | 114 | 117 | 112 | 118 | 116 | 115 | 109 | 104 | ||||||
| Inventory Net | 58 | 58 | 54 | 58 | 60 | 59 | 59 | 65 | 70 | 71 | 72 | 75 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 214 | 214 | 215 | 227 | 238 | 229 | 221 | 235 | 234 | 229 | 223 | 229 | ||||||
| Prepaid Expense Current | 11 | 11 | 10 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 8 | 11 | ||||||
| Income Taxes Receivable | 7 | 7 | 7 | 15 | 14 | 14 | 10 | 15 | 15 | 14 | 14 | 17 | ||||||
| Other Assets Current | 7 | 7 | 7 | 8 | 8 | 6 | 11 | 6 | 5 | 4 | 5 | 5 | ||||||
| Property Plant And Equipment Net | 100 | 100 | 99 | 98 | 98 | 98 | 97 | 98 | 99 | 99 | 100 | 99 | ||||||
| Operating Lease Right Of Use Asset | 53 | 55 | 54 | 54 | 55 | 57 | 56 | 57 | 56 | 54 | 54 | 53 | ||||||
| Intangible Assets Net Excluding Goodwill | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | ||||||
| Goodwill | 106 | 106 | 106 | 100 | 100 | 99 | 99 | 99 | 99 | 99 | 99 | 99 | ||||||
| Deferred Income Tax Assets Net | 71 | 71 | 67 | 71 | 70 | 68 | 70 | 70 | 71 | 66 | 69 | 72 | ||||||
| Other Assets Noncurrent | 36 | 35 | 35 | 36 | 35 | 34 | 35 | 35 | 33 | 34 | 34 | 32 | ||||||
| Assets | 587 | 588 | 584 | 591 | 597 | 586 | 585 | 600 | 598 | 588 | 586 | 592 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 40 | 40 | 37 | 37 | 42 | 38 | 35 | 34 | 37 | 32 | 34 | 34 | ||||||
| Employee Related Liabilities Current | 22 | 22 | 27 | 23 | 25 | 24 | 23 | 22 | 22 | 20 | 19 | 19 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 101 | 105 | 106 | 96 | 105 | 104 | 102 | 95 | 98 | 85 | 88 | 84 | ||||||
| Operating Lease Liability Current | 12 | 12 | 11 | 11 | 12 | 12 | 11 | 11 | 11 | 10 | 10 | 10 | ||||||
| Taxes Payable Current | 2 | 4 | 4 | 4 | 4 | 5 | 10 | 5 | 8 | 4 | 7 | 5 | ||||||
| Other Accrued Liabilities Current | 17 | 17 | 17 | 9 | 9 | 10 | 8 | 9 | 9 | 9 | 8 | 9 | ||||||
| Long Term Debt And Capital Lease Obligations | 114 | 114 | 110 | 114 | 125 | 124 | 126 | 140 | 148 | 160 | 163 | 178 | ||||||
| Operating Lease Liability Noncurrent | 39 | 41 | 42 | 42 | 42 | 44 | 43 | 44 | 43 | 41 | 42 | 41 | ||||||
| Deferred Compensation Liability Classified Noncurrent | 30 | 28 | 29 | 31 | 30 | 29 | 31 | 32 | 31 | 30 | 31 | 29 | ||||||
| Deferred Income Tax Liabilities Net | 8 | 8 | 8 | 10 | 11 | 10 | 9 | 14 | 13 | 13 | 13 | 12 | ||||||
| Other Liabilities Noncurrent | 16 | 16 | 16 | 21 | 22 | 21 | 21 | 20 | 20 | 20 | 20 | 19 | ||||||
Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 116 | 115 | 110 | 114 | 113 | 114 | 110 | 113 | 113 | 115 | 110 | 109 | ||||||
| Retained Earnings Accumulated Deficit | 177 | 171 | 173 | 174 | 160 | 150 | 145 | 143 | 132 | 124 | 121 | 119 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -4 | ||||||
| Treasury Stock Value | -15 | -12 | -12 | -11 | -6 | -4 | -3 | -0 | -0 | -1 | -1 | -0 | ||||||
| Stockholders Equity | 279 | 275 | 266 | 271 | 262 | 254 | 247 | 251 | 246 | 237 | 230 | 225 | ||||||
| Minority Interest | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | ||||||
| Liabilities And Stockholders Equity | 587 | 588 | 584 | 591 | 602 | 592 | 585 | 600 | 598 | 588 | 586 | 592 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 7 | 6 | 6 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 319 | 319 | 321 | 321 | 319 | 317 | 314 | 319 | 318 | 318 | 316 | 319 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | 20 | 20 | 20 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | ||||||
| Shares Outstanding | 46 | 46 | 46 | 46 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | 47 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCore Laboratories Inc. /DE/ (CLB) — SEC Financial Statements & Analysis
Core Laboratories Inc. /DE/ (CLB) is a oil & gas field services, nec company, incorporated in DE. Core Laboratories Inc. /DE/ trades on NYSE as: CLB. Core Laboratories Inc. /DE/ (CLB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Core Laboratories Inc. /DE/ carries a market cap of $535.78M, a P/E ratio of 21.70x, a P/B ratio of 1.92x, a P/S ratio of 1.03x, an enterprise value of $626.90M, and an EV/EBITDA multiple of 10.01x. On profitability, it posts a gross margin of 40.86%, an operating margin of 9.21%, a net margin of 4.76%, a Return on Equity (ROE) of 9.14%, a Return on Assets (ROA) of 4.17%, and a Return on Invested Capital (ROIC) of 8.60%. Per share, it reports EPS of $0.54, diluted EPS of $0.53, free cash flow per share of $0.33, and a dividend per share of $0.04. Over the trailing year, it posted revenue growth of 0.35% year-over-year, net income growth of -19.31% year-over-year, and EPS growth of -18.26% year-over-year. On the balance sheet, it maintains a current ratio of 2.12x, a quick ratio of 1.44x, working capital of $113.31M, a debt-to-equity ratio of 0.36x, a debt ratio of 0.17, an interest coverage ratio of 4.35x, free cash flow of $15.14M (TTM), and net debt of $91.13M. Figures sourced from SEC EDGAR.
- Market Cap
- $535.78M
- P/E TTM
- 21.70x
- EPS TTM
- $0.54
- P/B TTM
- 1.92x
- ROE TTM
- 9.14%
- ROA TTM
- 4.17%
- Debt To Equity
- 0.36x
- Free Cash Flow TTM
- $15.14M
- Net Revenue TTM Growth 1Y
- 0.35%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Core Laboratories Inc. /DE/ in?
Core Laboratories Inc. /DE/ (CLB) operates in the Oil & Gas Field Services, NEC industry.
What exchange does CLB trade on?
Core Laboratories Inc. /DE/ (CLB) trades on the NYSE.
Where is Core Laboratories Inc. /DE/ incorporated?
Core Laboratories Inc. /DE/ is incorporated in DE.
When was Core Laboratories Inc. /DE/ (CLB)'s most recent SEC filing?
Core Laboratories Inc. /DE/ (CLB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30.
What is CLB's market cap?
Core Laboratories Inc. /DE/ (CLB) has a market capitalization of $535.78M as of 2026-06-30.
What is CLB's P/E ratio?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month P/E ratio is 21.70x as of 2026-06-30.
What is CLB's EPS (earnings per share)?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month EPS is $0.54 as of 2026-06-30.
What is CLB's ROE (return on equity)?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month Return on Equity (ROE) is 9.14% as of 2026-06-30.
What is CLB's ROA (return on assets)?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month Return on Assets (ROA) is 4.17% as of 2026-06-30.
What is CLB's ROIC (return on invested capital)?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month Return on Invested Capital (ROIC) is 8.60% as of 2026-06-30.
What is CLB's EV/EBITDA?
Core Laboratories Inc. /DE/ (CLB)'s trailing twelve month EV/EBITDA is 10.01x as of 2026-06-30.